NET PROFIT (x1000 NOK)
NeoProteomics AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 0 | 0 | 0 |
Financial expenses | 45 | 47 | 49 |
Earnings before taxes | -108 | -64 | -270 |
EBITDA | -62 | -19 | -222 |
Total assets | 5,466 | 5,541 | 5,972 |
Current assets | 106 | 24 | 46 |
Current liabilities | 4,206 | 4,205 | 4,468 |
Equity capital | 1,260 | 1,336 | 1,504 |
- share capital | 104 | 107 | 115 |
Employees (average) | 0 | 0 | 0 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 23.1% | 24.1% | 25.2% |
Turnover per employee | |||
Profit as a percentage of turnover | |||
Return on assets (ROA) | -1.2% | -0.3% | -3.7% |
Current ratio | 2.5% | 0.6% | 1.0% |
Return on equity (ROE) | -8.6% | -4.8% | -18.0% |
Change turnover | 0 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 0 | -2 |
Chg. No. of employees % | -100% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.